One Stop Solution For In-Depth Market Research Reports

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   North America Computed Tomography (CT) Market

North America Computed Tomography (CT) Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Product Code : MDHC00122341
Survey : Mordor Intelligence
Publish On : 12, August, 2022
Category : Healthcare and Pharmaceuticals
Study Area : North America (U.S. and Others), Europe (Germany, France, U.K. and Others), Asia-Pacific (Japan, China, India and Others), Rest of World (Brazil, Rest of Latin America, Middle East & Others)
Report format : PDF
Sales price option (consumption tax not included)
Single User USD4950 / Question Form
5 User USD6750 / Question Form
Enterprise User USD9000 / Question Form
 - Canon Medical Systems Corporation
- Fujifilm Holdings Corporation
- GE Healthcare
- Hitachi Healthcare Systems
- Koning Corporation
- Koninklijke Philips NV
- NeuroLogica Corporation
- Neusoft Medical Systems Co. Ltd
- Shenzhen Anke High-Tech Co.
- Siemens Healthineers

[Report Description]

The major factors for the growth of the North American computed tomography (CT) market include the rising geriatric population and increase in the incidences of chronic diseases, increase in the shift of medical care toward image-guided interventions, and technological advancements.

The burden of chronic diseases is on the rise, across the world, and medical imaging procedures play a crucial role in the accurate diagnosis of these diseases. Chronic diseases, such as heart disease, stroke, cancer, diabetes, obesity, and arthritis, are among the most common, expensive, and preventable health problems. According to the estimates of CDC, six in ten Americans live with at least one chronic disease, like heart disease, cancer, stroke, or diabetes. These, along with other chronic diseases, are the leading causes of death and disability in America, and they are the leading drivers of healthcare costs. Furthermore, chronic diseases are responsible for seven out of every 10 deaths in the United States, killing more than 1.7 million citizens every year. To prevent the impact of chronic diseases on individuals and the society, research is being conducted for the early detection of such disorders. The access to technology and the relative cost of CT procedures, as compared to other modalities, make it a preferred choice of imaging. CT scan is being increasingly used to diagnose these diseases, which is also increasing its demand. A similar trend is observed in Canada and in some parts of Mexico.

Key Market Trends

The Oncology Segment is Expected to Account for Largest Market Share, during the Forecast Period

Oncology deals with the diagnosis and treatment of tumors and cancers, while cancer is one of the leading causes of morbidity and mortality. In both the sexes, lung, breast, and colorectal cancers are among the most common cancers, across the world, with lung cancer alone contributing to more than 13% of the total cases diagnosed. Cancer has a major impact on society in the United States and across the world. As per the National Cancer Institute, in 2018, an estimated 1,735,350 new cases of cancer were diagnosed in the United States with 609,640 deaths. The most common cancers are breast cancer, lung and bronchus cancer, prostate cancer, colon and rectum cancer, melanoma of the skin, bladder cancer, non-Hodgkin lymphoma, kidney and renal pelvis cancer, endometrial cancer, leukemia, pancreatic cancer, thyroid cancer, and liver cancer.

Competitive Landscape

The North American computed tomography (CT) market is a fragmented one, owing to the presence of a several major players. The major market players, such as Canon Medical Systems Corporation, Koninklijke Philips NV, GE Healthcare, and Siemens Healthineers, hold significant shares in the industry. Most of the major players are focusing on bringing technologically advanced products into the market, in order to acquire the maximum shares.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format

  • 3 months of analyst support

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study



4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Geriatric Population and Burden of Chronic Diseases
4.2.2 Increase in Shift of Medical Care Toward Image-guided Interventions
4.2.3 Technological Advancements
4.3 Market Restraints
4.3.1 Lack of Adequate Reimbursement
4.3.2 Stringent Regulatory Framework
4.4 Porter s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5.1 By Type

5.1.1 Low Slice
5.1.2 Medium Slice
5.1.3 High Slice
5.2 By Application
5.2.1 Oncology
5.2.2 Neurology
5.2.3 Cardiovascular
5.2.4 Musculoskeletal
5.2.5 Other Applications
5.3 By End User
5.3.1 Hospitals
5.3.2 Clinics
5.3.3 Diagnostic Services
5.3.4 Other End Users
5.4 Geography
5.4.1 North America United States Canada Mexico

6.1 Company Profiles
6.1.1 Canon Medical Systems Corporation
6.1.2 Fujifilm Holdings Corporation
6.1.3 GE Healthcare
6.1.4 Hitachi Healthcare Systems
6.1.5 Koning Corporation
6.1.6 Koninklijke Philips NV
6.1.7 NeuroLogica Corporation
6.1.8 Neusoft Medical Systems Co. Ltd
6.1.9 Shenzhen Anke High-Tech Co.
6.1.10 Siemens Healthineers


Shibuya data count

Shibuya Data Count is a reseller offering a variety of market research reports from different industries, provided by a global team of experienced research professionals who ensure the most reliable and up-to-date research analysis reports.

Recommended reports